logo
Share SHARE
FONT-SIZE Plus   Neg

CHMP Adopts Negative Opinion On KYNAMROTM - Quick Facts

Genzyme, a Sanofi company (SNY), and Isis Pharmaceuticals Inc. (ISIS), announced the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency has adopted a negative opinion for its marketing authorization application for KYNAMROTM for the treatment of patients with Homozygous Familial Hypercholesterolaemia. Genzyme plans to request a re-examination of the CHMP Opinion.

An application for KYNAMRO is currently under review by the U.S. FDA.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Tinder launched a web version of its dating app, called Tinder Online, mainly focusing users in developing markets with limited storage on their mobile phones. The company also aims users in places where mobile phones are not welcome, like class rooms. Instead of swiping, they can either drag a prospective match's card to the right or left. Art supply company Crayola is dropping one color from its 24-count crayon box for the first time in over one hundred years of its history. The company hasn't yet revealed which color would be retiring. The company will live stream the decision on Friday, March 31, known as National Crayon Day. Yamaha Motor Co. is planning to recall multiple three-cylinder motorcycle models due to a safety issue with the lower handlebar, Asphalt & Rubber has reported. According to the report, the stud bolt threads might not have enough thread-locking agent applied to them due to the lower handlebar being improperly painted.
comments powered by Disqus
Follow RTT